Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Evaluation of Health Related Questionnaire Among Mycosis Fungoides and Lymphomatoid Papulosis

Rakhshandra Talpur, MD, Iris Wieser, MD, Casey Wang, Lyons Genevieve, Madeleine Duvic, MD

Blood (2015) 126 (23): 5603.

https://doi.org/10.1182/blood.V126.23.5603.5603

Published: 2015

Journal Articles

Lymphomatoid Papulosis: Assessing Treatment Response and Associated Lymphomas in a Study of 180 Patients

Iris Wieser, MD, Chee Won Oh, MD PhD, Rakhshandra Talpur, MD, Madeleine Duvic, MD

Blood (2015) 126 (23): 1487.

https://doi.org/10.1182/blood.V126.23.1487.1487

Published: 2015

Journal Articles

Clinical Features of Folliculotrophic Mycosis Fungoides

Wang Casey, MD, Rakhshandra Talpur, MD, Silvia Alberti-Violetti, MD, Iris Wieser, MD, Casey Tran, Madeleine Duvic, MD

Blood (2015) 126 (23): 1488.

https://doi.org/10.1182/blood.V126.23.1488.1488

Published: 2015

Journal Articles

Primary Cutaneous Small to Medium-Size CD4+ Pleomorphic T-Cell Lymphoma: 48 Patients from Two Independent Centers and Revaluation of Clinico-Histological Criteria for Differential Diagnosis from Other CTCL

Silvia Alberti-Violetti, MD, Rakhshandra Talpur, MD, Carlos Antonio Torres-Cabala, MD, Laura Corti, PhD, Emilio Berti, MD, Madeleine Duvic, MD

Blood (2014) 124 (21): 2986.

https://doi.org/10.1182/blood.V124.21.2986.2986

Published: 2014

Journal Articles

Prognostic Factors, Staging and Treatments in Advanced Stage Mycosis Fungoides and Sézary Syndrome

Rakhshandra Talpur, MD, Silvia Alberti-Violetti, MD, Megan Schilti, Dawen Sui, MS, Madeleine Duvic, MD

Blood (2014) 124 (21): 1673.

https://doi.org/10.1182/blood.V124.21.1673.1673

Published: 2014

Journal Articles

A Single Center Experience With Pralatrexate Alone Or In Combination With Bexarotene: Long Term Responses In Advanced Stage Relapsed/Refractory Cutaneous T-Cell Lymphoma

Rakhshandra Talpur, MD, Andrew Thompson, Pamela Gangar, Madeleine Duvic, MD

Blood (2013) 122 (21): 5113.

https://doi.org/10.1182/blood.V122.21.5113.5113

Published: 2013

Journal Articles

Phase II Trial Of Brentuximab Vedotin For CD30+ Cutaneous T-Cell Lymphomas and Lymphoproliferative Disorders

Madeleine Duvic, MD, Michael Tetzlaff, MD, Audra L Clos, MD, Pamela Gangar, MD, Rakhshandra Talpur, MD

Blood (2013) 122 (21): 367.

https://doi.org/10.1182/blood.V122.21.367.367

Published: 2013

Journal Articles

Results of a Phase II Trial of Brentuximab Vedotin (SGN-35) for CD30+ Cutaneous T-Cell Lymphomas and Lymphoproliferative Disorders

Madeleine Duvic, MD, Michael Tetzlaff, MD, Audra L Clos, MD, Pamela Gangar, MD, Rakhshandra Talpur, MD

Blood (2012) 120 (21): 3688.

https://doi.org/10.1182/blood.V120.21.3688.3688

Published: 2012

Journal Articles

Long-Term Complete Responses to Combination Therapies in Sézary Patients.

Seema Daulat, MD, Rakhshandra Talpur, Chitra Hosing, Madeleine Duvic, MD

Blood (2009) 114 (22): 3369.

https://doi.org/10.1182/blood.V114.22.3369.3369

Published: 2009

Journal Articles

Multicenter Trial of Photopheresis in Early Stage Mycosis Fungoides

Madeleine Duvic, MD, Rakhshandra Talpur, MD, Elma D Baron, MD, Larisa J. Geskin, MD, Marie-France Demierre, MD, John Zic, MD, Kimberly Bohjanan, MD

Blood (2008) 112 (11): 4942.

https://doi.org/10.1182/blood.V112.11.4942.4942

Published: 2008

Journal Articles

Overall Survival in Erythrodermic Cutaneous T-Cell Lymphoma: An Analysis of Prognostic Factors in a Cohort of Erythrodermic Cutaneous T-Cell Lymphoma Patients.

Kelley A. Vidulich, MD, Rakhshandra Talpur, M.D., Roland L. Bassett, M.S., Madeleine Duvic, M.D.

Blood (2007) 110 (11): 3574.

https://doi.org/10.1182/blood.V110.11.3574.3574

Published: 2007

Journal Articles

Biomarkers of Vorinostat Resistance in Cutaneous T-Cell Lymphoma.

Chunlei Zhang, MD, PhD, Baoqiang Li, MD, Rakhshandra Talpur, MD, C. Cameron Yin, MD, PhD, Madeleine Duvic, MD

Blood (2007) 110 (11): 1381.

https://doi.org/10.1182/blood.V110.11.1381.1381

Published: 2007

Journal Articles

Cytomegalovirus seropositivity is significantly associated with mycosis fungoides and Sézary syndrome: Presented in part at the 43rd annual meeting of the American Society of Hematology, Orlando, FL, December 8-11, 2001, and at the annual meeting of the American Academy of Dermatology, New Orleans, LA, February 24-28, 2002.

Kelly L. Herne, Rakhshandra Talpur, Joan Breuer-McHam, Richard Champlin, Madeleine Duvic

Blood (2003) 101 (6): 2132–2135.

https://doi.org/10.1182/blood-2002-07-2247

Published: 2003

NARROW

Evaluation of Health Related Questionnaire Among Mycosis Fungoides and Lymphomatoid Papulosis

Lymphomatoid Papulosis: Assessing Treatment Response and Associated Lymphomas in a Study of 180 Patients

Clinical Features of Folliculotrophic Mycosis Fungoides

Primary Cutaneous Small to Medium-Size CD4+ Pleomorphic T-Cell Lymphoma: 48 Patients from Two Independent Centers and Revaluation of Clinico-Histological Criteria for Differential Diagnosis from Other CTCL

Prognostic Factors, Staging and Treatments in Advanced Stage Mycosis Fungoides and Sézary Syndrome

A Single Center Experience With Pralatrexate Alone Or In Combination With Bexarotene: Long Term Responses In Advanced Stage Relapsed/Refractory Cutaneous T-Cell Lymphoma

Phase II Trial Of Brentuximab Vedotin For CD30+ Cutaneous T-Cell Lymphomas and Lymphoproliferative Disorders

Results of a Phase II Trial of Brentuximab Vedotin (SGN-35) for CD30+ Cutaneous T-Cell Lymphomas and Lymphoproliferative Disorders

Long-Term Complete Responses to Combination Therapies in Sézary Patients.

Multicenter Trial of Photopheresis in Early Stage Mycosis Fungoides

Overall Survival in Erythrodermic Cutaneous T-Cell Lymphoma: An Analysis of Prognostic Factors in a Cohort of Erythrodermic Cutaneous T-Cell Lymphoma Patients.

Biomarkers of Vorinostat Resistance in Cutaneous T-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only